·
EDITORIAL
·
Catalytic biomaterials: driving innovation in biology, pharmacy, and medicine
Show Less
1
Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai,
China
BMT 2025 , 6(1), 1–3;
https://doi.org/10.12336/biomatertransl.2025.01.001
Submitted: 9 February 2025 | Revised: 11 March 2025 | Accepted: 12 March 2025 | Published: 25 March 2025
Copyright © 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution–NonCommercial–ShareAlike 4.0 License.
Funding
The authors greatly acknowledge the financial support from the National Natural Science Foundation of China (Grant Nos. 52102350), The Chenguang Program of the Shanghai Education Development Foundation and Shanghai Municipal Education Commission, and the Wenzhou Basic Scientific Research Project (Grant No. Y20230135).
References
Below is the content of the Citations in the paper which has been de-formatted, however, the content stays consistent with the original.
- Cormode DP, Gao LZ, Koo H. Emerging biomedical applications of enzyme-like catalytic nanomaterials. Trends Biotechnol. 2018;36(1):15-29. doi: 10.1016/j.tibtech.2017.09.006
- Song XR, Yu LD, Chen L, Chen Y. Catalytic biomaterials. Acc Mater Res. 2024;5(3):271-285. doi: 10.1021/accountsmr.3c00230
- Huang H, Wang ZY, Chen L, Yu H, Chen Y. Catalytic biomaterials and nanomedicines with exogenous and endogenous activations. Adv Healthc Mater. 2023;12(16):2201607. doi: 10.1002/adhm.202201607
- Zhao B, Zeng LT, Chen DY, et al. NIR-photocatalytic regulation of arthritic synovial microenvironment. Sci Adv. 2022;8(40):eabq0959. doi: 10.1126/sciadv.abq0959
- Xiang HJ, Feng W, Chen Y. Single-atom catalysts in catalytic biomedicine. Adv Mater. 2020;32(8):1905994. doi: 10.1002/adma.201905994
- Feng W, Han XG, Hu H, et al. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases. Nat Commun. 2021;12(1):2203. doi: 10.1038/s41467-021-22278-x
- Ge M, Zhu WB, Mei JW, et al. Piezoelectric-enhanced nanocatalysts trigger neutrophil N1 polarization against bacterial biofilm by disrupting redox homeostasis. Adv Mater. 2024;37(6):2409633. doi: 10.1002/adma.202409633
- Wang HJ, He WJ, Liao J, et al. Catalytic biomaterials-activated in situ chemical reactions: Strategic modulation and enhanced disease treatment. Adv Mater. 2025;37(1):2411967. doi: 10.1002/adma.202411967
- Wang LP, Ji PH, Yu JD, et al. Hybridized and engineered microbe for catalytic generation of peroxynitrite and cancer immunotherapy under sonopiezo initiation. Sci Adv. 2024;10(44):eadp7540. doi: 10.1126/sciadv.adp7540
- Wu XB, Li YQ, Wen M, et al. Nanocatalysts for modulating antitumor immunity: Fabrication, mechanisms and applications. Chem Soc Rev. 2024;53(5):2643-2692. doi: 10.1039/D3CS00673E
Conflict of interest
The authors declare no competing interests.
